Prenetics Global Limited operates as an independent parent corporate entity and is not a subsidiary owned by a larger conglomerate. Following its historical evolution and public market debut on the NASDAQ exchange via a business combination with a special purpose acquisition company, it functions as the ultimate parent structure overseeing its various operational health sciences, genetic testing, and consumer longevity brands globally.